Hidradenitis suppurativa trials in Denmark
4 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Where
- Roskilde
- Age
- 18 years to 100 years
- People
- 710 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Roskilde
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 4Not yet taking people in DenmarkAdalimumab Treatment for Patients with Hidradenitis Suppurativa at high risk of Severe Disease
- Where
- Hellerup
- Age
- 18 years to 64 years
- People
- 100
- Run by
- Gentofte Hospital
See details and how to join2025-522505-37-00 - Phase 4Taking peopleBotox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study
- Where
- Hellerup
- Age
- 18 years and over
- People
- 20
- Run by
- Gentofte Hospital
See details and how to join2024-519946-54-00